MedPath

四川太平洋药业有限责任公司

Ownership
-
Established
1997-01-06
Employees
-
Market Cap
-
Website
http://www.btyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

NMPA:99

Drug Approvals

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258022
Approval Date
Feb 27, 2025
NMPA

Ciprofloxacin Lactate and Sodium Chloride Injection

Product Name
乳酸环丙沙星氯化钠注射液
Approval Number
国药准字H20247229
Approval Date
Sep 30, 2024
NMPA

银柴颗粒

Approval Number
国药准字Z51021527
Approval Date
Sep 28, 2022
NMPA

穿心莲片

Approval Number
国药准字Z51021525
Approval Date
Sep 28, 2022
NMPA

板蓝根颗粒

Approval Number
国药准字Z51021524
Approval Date
Sep 28, 2022
NMPA

益母草颗粒

Approval Number
国药准字Z51021526
Approval Date
Sep 28, 2022
NMPA

复方黄连素片

Approval Number
国药准字Z51021296
Approval Date
Sep 28, 2022
NMPA

玄麦甘桔颗粒

Approval Number
国药准字Z51021300
Approval Date
Sep 28, 2022
NMPA

小柴胡颗粒

Approval Number
国药准字Z51021299
Approval Date
Sep 28, 2022
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H51023342
Approval Date
Jul 13, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.